Last edition
News about "Azstarys"
China Approves Azstarys for ADHD Treatment
ArkBio secures NMPA nod for once-daily ADHD treatment in China.
Azstarys | 06/01/2026 | By News Bureau | 330
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members